Seeing Is Believing
Healthcare - Sector
PSTV is currently covered by 3 analysts with an average price target of $29. This is a potential upside of $-621.73 (655.21%) from yesterday's end of day stock price of $3.84.
Plus Therapeutics's activity chart (see below) currently has 24 price targets and 57 ratings on display. The stock rating distribution of PSTV is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 44.81% with an average time for these price targets to be met of 338 days.
Highest price target for PSTV is $57, Lowest price target is $1, average price target is $29.
Most recent stock forecast was given by from ASCENDIANT on 08-Jun-2026. First documented stock forecast 28-Jun-2016.
Currently out of the existing stock ratings of PSTV, 16 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Jan-2020
$57
$52.8 (1257.14%)
$65
3 months 6 days ago
(08-Jun-2026)
1/4 (25%)
$51.47 (930.74%)
831
Buy Since 18-Sep-2025
5 months 14 days ago
(31-Mar-2026)
3/5 (60%)
$4.54 (986.96%)
119
Buy Since 11-Feb-2021
$1
$-3.2 (-76.19%)
$2
7 months 22 days ago
(23-Jan-2026)
5/7 (71.43%)
$0.73 (270.37%)
266
Buy Since 16-Oct-2020
$3
$-1.2 (-28.57%)
1 years 27 days ago
(18-Aug-2025)
2/5 (40%)
$2.46 (455.56%)
499
Buy Since 24-Apr-2023
$10
$5.8 (138.10%)
$71
1 years 9 months 27 days ago
(18-Nov-2024)
0/3 (0%)
$8.81 (740.34%)
What is PSTV (Plus Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on PSTV (Plus Therapeutics)?
Which analyst has the most public recommendations on PSTV (Plus Therapeutics)?
Which analyst is the currently most bullish on PSTV (Plus Therapeutics)?
Which analyst is the currently most reserved on PSTV (Plus Therapeutics)?